礼来再创减肥新突破,日服GLP-1药物orforglipron显效。
Lilly scores again in weight loss with daily GLP-1 orforglipron
生物技术与制药领域的最新动态
Lilly scores again in weight loss with daily GLP-1 orforglipron
Alnylam, INCOG and Novartis expand in US; Ember gets $16.5M Series A
Takeda says $4B TYK2 drug succeeds in large psoriasis studies
“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina
Recent discoveries on the acquisition of the highest levels of human performance | Science
AQP5: A functional gastric cancer stem cell marker in mouse and human tumors | Science
Ancient genomes illuminate the origins and dynamic history of East Asian cattle | Science
Conformational landscape adaptations enable processive phosphorylation by Src family kinases | Science
Optimal perovskite vapor partitioning on textured silicon for high-stability tandem solar cells | Science
Identification of intestinal enteroendocrine cell subtypes and their associated hormones in zebrafish
Post-transcriptional suppression of the pioneer factor Zelda protects the adult Drosophila testis from activation of the ovary program
The master virulence regulator PhoP dictates carbon metabolism by controlling cyclic AMP synthesis in Salmonella
Paralogs of Slitrk cell adhesion molecules configure excitatory synapse specificity via distinct cellular mechanisms
2025: A year of resilience and resourcefulness
Atavistik raises $120M for bleeding disorder, blood cancer drugs
Insilico advances Hong Kong IPO, eyes $260M raise with Lilly's support
Is Waters Corporation stock a safe buy before earnings - Trade Volume Summary & AI Forecast Swing Trade Picks - Улправда
Osprey Private Wealth LLC Has $7.94 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
New LDHA inhibitors disclosed for autoimmune diseases
Alicorn Pharmaceutical discovers new PRMT5 inhibitors